References
- Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974; 33(6)1607–9
- Willox JC, Corr J, Shaw J, Richardson M, Calman KC, Drennan M. Prednisolone as an appetite stimulant in patients with cancer. Br Med J (Clin Res Ed) 1984; 288(6410)27
- Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 1985; 69(7–8)751–4
- Della Cuna GR, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 1989; 25(12)1817–21
- Popiela T, Lucchi R, Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 1989; 25(12)1823–9
- Needham PR, Daley AG, Lennard RF. Steroids in advanced cancer: Survey of current practice [see comments]. BMJ 1992; 305(6860)999
- Hardy JR, Rees E, Ling J, Burman R, Feuer D, Broadley K, et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 2001; 15(1)3–8
- Hanks GW, Trueman T, Twycross RG. Corticosteroids in terminal cancer–a prospective analysis of current practice. Postgrad Med J 1983; 59(697)702–6
- Adunsky, A, Berkowitz, M, Waller, A. Corticosteroids in terminal cancer. Harefuah 1995;128(5):278–80, 335.
- Mercadante S, Fulfaro F, Casuccio A. The use of corticosteroids in home palliative care. Support Care Cancer 2001; 9(5)386–9
- Gannon C, McNamara P. A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manage 2002; 24(3)328–34
- Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, et al. Drugs in palliative care: results from a representative survey in Germany. Palliat Med 2004; 18(2)100–7
- Lundstrom S, Strang P. Establishing and testing a palliative care research network in Sweden. Palliat Med 2004; 18(2)139
- Lundstrom S, Bystrom E, Gyllenhammar E, Martinsson U, Norrstrom B, Strang P. Palliative medicine network promotes research and development. Lakartidningen 2005; 102(16)1235–8
- Lundstrom S, Furst CJ. Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat Med 2003; 17(6)503–8
- Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol 2005; 23(9)2028–37
- Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114(9)735–40